Loading...
Loading...

by Ipca Laboratories Ltd· 15s
SKU: 1159197
You save ₹133 on this order
Inclusive of all taxes
IPCA MMF 500 TABLET belongs to a class of medicines known as immunosuppressants.
It is commonly used in combination with other immunosuppressive agents such as
ciclosporin and corticosteroids to support the acceptance of transplanted organs
like kidney, heart, or liver. The tablet contains mycophenolate mofetil, which
acts by lowering the activity of the immune cells that are typically activated
during autoimmune conditions or following organ transplantation. This action
reduces the immune system’s response, helping to maintain the function and
longevity of the transplanted organ.
The dosage of IPCA MMF 500 TABLET and how frequently it is taken varies
depending on the type of organ transplant received. Always follow your doctor’s
guidance for exact dosing. For o
an empty stomach at least one hour before or two hours after a meal unless your
healthcare provider advises differently. Swallow the tablet whole without
crushing, chewing, or breaking it. Consistent, regular use is important to
support the transplanted organ’s function and maintain its health over time.
Continue the medication as prescribed, even if you feel well, to uphold ongoing
organ stability.
The most common side effects of IPCA MMF 500 TABLETt include nausea, vomiting,
diarrhoea, stomach pain, headache, high blood pressure, and swelling in the
ankles or feet. Patients may experience infections caused by bacteria, viruses,
or fungi due to the immune-modulating effects of the medicine. Changes in white
blood cell counts are common, which can increase susce
and may also raise the chance of certain cancers over long-term use. To lower
the risk of skin-related issues, it is advisable to limit sun exposure and use a
high-protection sunscreen. There is a broad range of possible side effects
associated with this medication, so it is important to consult your healthcare
provider to understand what symptoms to watch for. Some side effects can be
serious and require immediate medical attention.
IPCA MMF 500 TABLET may cause serious risks during pregnancy, including birth
defects and pregnancy loss, so it should not be used if you are pregnant, trying
to conceive, or breastfeeding. It is essential to discuss with your doctor
before starting this medicine, especially if you show any signs of infection,
unexpected bruising, or bleeding. Inform your healthcare provider about all
other medications, supplements, or herbal products you are taking, as they can
influence how IPCA MMF 500 TABLET works or be affected by it. While on this
medication, regular blood tests will be necessary to monitor changes in your
blood cell counts, as well as sugar and cholesterol levels, ensuring your safety
and the medicine’s o
01)Supports Organ Acceptance After Transplant:IPCA MMF 500 TABLET, when used
with ciclosporin and corticosteroids, helps moderate the immune system’s
activity to support the acceptance and sustained health of transplanted organs
like kidney, heart, or liver.
02)Selective Immune Cell Inhibition:The active ingredient, mycophenolate
mofetil, selectively reduces the proliferation of T and B lymphocytes, cells
that play a crucial role in immune response linked to organ transplantation and
autoimmune conditions.
03)Minimizes Immune System Activity Linked to Organ Response:By targeting
key enzymes in nucleotide synthesis, IPCA MMF 500 TABLET lowers immune cell
activity that could otherwise compromise the transplanted organ.
04)Non-Nephrotoxic Immunosuppressive O
IPCA MMF 500 TABLET does not cause kidney toxicity or promote fibrotic tissue
formation, making it a safer choice for long-term use.
05)Supports Long-Term Stability of Transplanted Organs:Regular use under
medical supervision helps maintain the function and integrity of transplanted
organs over time.
06)Suitable for Adult and Pediatric Patients:IPCA MMF 500 TABLET is approved
for both adult and children aged 1 year and older, facilitating transplant
success across age groups.
IPCA MMF 500 TABLET contains mycophenolate mofetil, which is converted in the
body to mycophenolic acid. This active compound selectively reduces the
proliferation of immune cells that are activated following organ transplantation
or autoimmune responses, helping to maintain immune balance and support
transplant success.
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), a
key enzyme necessary for the de novo synthesis of guanosine nucleotides. Since T
and B lymphocytes rely heavily on this pathway for their growth and function,
this inhibition leads to a reduced immune cell proliferation, moderating immune
reactions.
By targeting the synthesis of guanosine nucleotides, IPCA MMF 500 TABLET lowers
the activity and replication of T and B lymphocytes, critical cells in immune
response, thereby supporting the body's acceptance of the transplanted organ and
reducing damaging immune activity.
IPCA MMF 500 TABLET active metabolite blocks the rate-limiting step in purine
synthesis, depleting nucleotide pools required for DNA and RNA synthesis in
lymphocytes. This biochemical interru
function without affecting other cell types that use alternate pathways.
IPCA MMF 500 TABLET is used as part of combination immunosuppressive therapy to
modulate immune response and support the transplanted organ's function and
longevity, thereby enhancing overall transplant outcomes and patient health.
By selectively inhibiting lymphocyte proliferation and reducing inflammation,
IPCA MMF 500 TABLET modulates the immune system’s activity, helping to maintain
a balanced response that supports the survival of transplanted organs while
minimizing unwanted immune reactions.
!### Diarrhea
!### Nausea And Vomiting
!### Stomach Pain
!### Pregnancy
ContraindicatedIPCA MMF 500 TABLET is not recommended during pregnancy due to the high risk of
miscarriage and birth defects. Women planning pregnancy or who are pregnant
should inform their doctor before taking this medicine. Effective contrace
is essential for women of childbearing potential during management and for at
least 6 months after discontinuation. Consult your doctor if you are pregnant or
planning to conceive before taking this medicine.
!### Breastfeeding
ContraindicatedMycophenolate mofetil can passes into breast milk and may harm the nursing
infant. Breastfeeding is not advised during IPCA MMF 500 TABLET therapy. Discuss
alternatives with your healthcare provider if planning to breastfeed. Consult
with your doctor before taking it.
!### Driving and Using Machines
Use with CautionAvoid driving or using machinery if you experience side effects such as
drowsiness or dizziness or tremors or low blood pressure, or numbness.
!### Allergy
ContraindicatedDo not use IPCA MMF 500 TABLET if you have a known allergy to mycophenolate
mofetil or any other ingredient in the tablet.
!### Use In Pediatrics
Consult your doctorThis medicine is not recommended for use in children under the age of 2, because
there is limited information on its safety and effectiveness. Consult your
paediatrician before giving it.
!### Use In Geriatrics
Use with CautionElderly patients (65 years and above) should use IPCA MMF 500 TABLET cautiously,
especially if they are prone to viral infections, gastrointestinal bleeding, or
pulmonary oedema. Consult with your doctor before taking it.
Before Taking IPCA MMF 500 TABLET, Inform Your Doctor If You:
IPCA MMF 500 TABLET is not recommended for use if you:
| Lifestyle & Safety Measures | Details |
| Sun Protection for Photosensitivity | Limit direct sun exposure; wear protective clothing covering arms, legs, neck, and head; use sunscreen with high SPF to reduce skin damage risk. |
| Infection Risk Management | Avoid close contact with people showing signs of infection (e.g., chickenpox, shingles, flu), maintain good hygiene, frequent handwashing, and promptly report fever or signs of infection to your doctor. |
| Vaccination Precautions | Avoid live vaccines during IPCA MMF 500 TABLET therapy as they may cause infections due to weakened immunity. consult your doctor for updated vaccine schedules and alternatives. |
| Dietary Recommendations | Consume a balanced diet rich in fruits, vegetables, and protein to support overall health, avoid unpasteurized dairy, deli meats, and undercooked foods which increase infection risk. |
| Medication Adherence | Take IPCA MMF 500 TABLET on an empty stomach, 1 hour before or 2 hours after meals, unless advised otherwise, swallow tablets whole without crushing or chewing. |
| Regular Medical Monitoring | Attend routine blood tests to monitor immune function and detect potential side effects promptly, ensuring safe continued use. |
01)Proton Pump Inhibitors (e.g., Omeprazole, Pantoprazole, Lansoprazole)
Interaction:Taking IPCA MMF 500 TABLET with PPIs can reduce the effectiveness
of IPCA MMF 500 TABLET by lowering its levels in the body.
Effects: Decreased immunosuppressive activity may impact transplant organ
acceptance. Management: Inform your doctor if you are using PPIs; close
monitoring and possible dose adjustments may be required.
02)Certain Antibiotics (e.g., Sulfamethoxazole/Trimethoprim, Ciprofloxacin,
Amoxicillin) Interaction: These antibiotics can reduce the absor
effectiveness of IPCA MMF 500 TABLET. Effects: Lowered drug levels may
compromise medication performance. Management: Healthcare providers may
monitor for reduced efficacy and adjust doses accordingly.
03)Antacids Containing Aluminum or Magnesium (e.g., Maalox, Mylanta)
Interaction: May decrease IPCA MMF 500 TABLET absor
concurrently. Effects: Reduced drug levels can impact therapeutic
outcomes. Management: Separate administration times between IPCA MMF 500
TABLET and antacids; consult your doctor for guidance.
04)Other Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Sirolimus)
Interaction: Concurrent use with IPCA MMF 500 TABLET increases the risk of
additive immunosuppression and side effects. Effects: Elevated risk of
infections and toxicity. Management: Regular monitoring and dose
modifications as advised by healthcare practitioners.
05)Bile Acid Sequestrants (e.g., Cholestyramine, Colesevelam)
Interaction: Can reduce IPCA MMF 500 TABLET absor
Effects: Potential decrease in immunosuppressive action.
Management: Avoid simultaneous use or monitor drug effectiveness closely.
01)High-Fat Foods Interaction: Consuming high-fat meals around the time
of IPCA MMF 500 TABLET dosing can reduce the absor
Effects: Lowered medication levels may decrease its effectiveness.
Management: It is recommended to avoid fatty foods close to dose times and
take IPCA MMF 500 TABLET on an empty stomach for better absor
02)Deli Meats and Foods That May Contain Listeria Interaction: Foods like
deli meats, soft cheeses, and unpasteurized milk may carry Listeria bacteria,
posing a risk due to weakened immune response from IPCA MMF 500 TABLET.
Effects: Increased risk of infections and foodborne illness.
Management: Avoid these foods while on IPCA MMF 500 TABLET therapy to reduce
infection risks.
03)Raw or Undercooked Meats Interaction: Consum
raw meats can increase the likelihood of bacterial or viral infections.
Effects: Heightened risk of food poisoning, which can be severe in
immunocompromised patients. Management: Always consume thoroughly cooked
meats and practice food hygiene.
04)Alcohol Interaction:Alcohol may further suppress immune function and
interact negatively with IPCA MMF 500 TABLET. Effects: Increased
susce
Management: Limit or avoid alcohol during IPCA MMF 500 TABLET management,
consult your doctor for personalized advice.
05)Antacids Containing Aluminum or Magnesium Interaction: Certain
antacids can decrease IPCA MMF 500 TABLET absor
Effects: Reduced drug levels may impact therapeutic outcomes.
Management: Take antacids at least 2 hours after IPCA MMF 500 TABLET or
avoid concurrent usage.
| Drug | : | Mycophenolate mofetil |
| Pharmacological Category | : | Immunosuppressants |
| Therapeutic Indication | : | Immune Suppression |
| Dosage Forms | : | Tablet, Capsule, Suspension, Oral suspension |
A: IPCA MMF 500 TABLET supports management of organ transplant patients by
modulating immune response to help maintain the acceptance and long-term
function of transplanted kidneys, hearts, or livers.
A: IPCA MMF 500 TABLET contains mycophenolate mofetil, which reduces immune cell
activity involved in organ rejection by inhibiting a key enzyme required for
immune cell growth and replication.
A: It is advisable to take IPCA MMF 500 TABLET on an empty stomach, at least one
hour before or two hours after meals, to ensure o
effectiveness.
A: Patients may experience nausea, diarrhoea, headache, stomach pain, high blood
pressure, and increased risk of infections due to its immune-modulating effects.
A: IPCA MMF 500 TABLET is not recommended during pregnancy as it may cause birth
defects or pregnancy loss. Women of childbearing age should use effective
contrace
A: Avoid live vaccines, limit exposure to sunlight to reduce photosensitivity
risk, practice good hygiene to minimize infection risk, and attend regular blood
tests to monitor health status.
A: Visit the official medicalslot website, search for IPCA MMF 500 TABLET, upload a
valid doctor’s prescri
provide an accurate delivery address. medicalslot will verify your prescri
before processing the order to ensure you receive genuine medication safely at
your doorstep.
IPCA MMF 500 TABLET belongs to a class of medicines known as immunosuppressants.
It is commonly used in combination with other immunosuppressive agents such as
ciclosporin and corticosteroids to support the acceptance of transplanted organs
like kidney, heart, or liver. The tablet contains mycophenolate mofetil, which
acts by lowering the activity of the immune cells that are typically activated
during autoimmune conditions or following organ transplantation. This action
reduces the immune system’s response, helping to maintain the function and
longevity of the transplanted organ.
The dosage of IPCA MMF 500 TABLET and how frequently it is taken varies
depending on the type of organ transplant received. Always follow your doctor’s
guidance for exact dosing. For o
an empty stomach at least one hour before or two hours after a meal unless your
healthcare provider advises differently. Swallow the tablet whole without
crushing, chewing, or breaking it. Consistent, regular use is important to
support the transplanted organ’s function and maintain its health over time.
Continue the medication as prescribed, even if you feel well, to uphold ongoing
organ stability.
The most common side effects of IPCA MMF 500 TABLETt include nausea, vomiting,
diarrhoea, stomach pain, headache, high blood pressure, and swelling in the
ankles or feet. Patients may experience infections caused by bacteria, viruses,
or fungi due to the immune-modulating effects of the medicine. Changes in white
blood cell counts are common, which can increase susce
and may also raise the chance of certain cancers over long-term use. To lower
the risk of skin-related issues, it is advisable to limit sun exposure and use a
high-protection sunscreen. There is a broad range of possible side effects
associated with this medication, so it is important to consult your healthcare
provider to understand what symptoms to watch for. Some side effects can be
serious and require immediate medical attention.
IPCA MMF 500 TABLET may cause serious risks during pregnancy, including birth
defects and pregnancy loss, so it should not be used if you are pregnant, trying
to conceive, or breastfeeding. It is essential to discuss with your doctor
before starting this medicine, especially if you show any signs of infection,
unexpected bruising, or bleeding. Inform your healthcare provider about all
other medications, supplements, or herbal products you are taking, as they can
influence how IPCA MMF 500 TABLET works or be affected by it. While on this
medication, regular blood tests will be necessary to monitor changes in your
blood cell counts, as well as sugar and cholesterol levels, ensuring your safety
and the medicine’s o
01)Supports Organ Acceptance After Transplant:IPCA MMF 500 TABLET, when used
with ciclosporin and corticosteroids, helps moderate the immune system’s
activity to support the acceptance and sustained health of transplanted organs
like kidney, heart, or liver.
02)Selective Immune Cell Inhibition:The active ingredient, mycophenolate
mofetil, selectively reduces the proliferation of T and B lymphocytes, cells
that play a crucial role in immune response linked to organ transplantation and
autoimmune conditions.
03)Minimizes Immune System Activity Linked to Organ Response:By targeting
key enzymes in nucleotide synthesis, IPCA MMF 500 TABLET lowers immune cell
activity that could otherwise compromise the transplanted organ.
04)Non-Nephrotoxic Immunosuppressive O
IPCA MMF 500 TABLET does not cause kidney toxicity or promote fibrotic tissue
formation, making it a safer choice for long-term use.
05)Supports Long-Term Stability of Transplanted Organs:Regular use under
medical supervision helps maintain the function and integrity of transplanted
organs over time.
06)Suitable for Adult and Pediatric Patients:IPCA MMF 500 TABLET is approved
for both adult and children aged 1 year and older, facilitating transplant
success across age groups.
IPCA MMF 500 TABLET contains mycophenolate mofetil, which is converted in the
body to mycophenolic acid. This active compound selectively reduces the
proliferation of immune cells that are activated following organ transplantation
or autoimmune responses, helping to maintain immune balance and support
transplant success.
Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), a
key enzyme necessary for the de novo synthesis of guanosine nucleotides. Since T
and B lymphocytes rely heavily on this pathway for their growth and function,
this inhibition leads to a reduced immune cell proliferation, moderating immune
reactions.
By targeting the synthesis of guanosine nucleotides, IPCA MMF 500 TABLET lowers
the activity and replication of T and B lymphocytes, critical cells in immune
response, thereby supporting the body's acceptance of the transplanted organ and
reducing damaging immune activity.
IPCA MMF 500 TABLET active metabolite blocks the rate-limiting step in purine
synthesis, depleting nucleotide pools required for DNA and RNA synthesis in
lymphocytes. This biochemical interru
function without affecting other cell types that use alternate pathways.
IPCA MMF 500 TABLET is used as part of combination immunosuppressive therapy to
modulate immune response and support the transplanted organ's function and
longevity, thereby enhancing overall transplant outcomes and patient health.
By selectively inhibiting lymphocyte proliferation and reducing inflammation,
IPCA MMF 500 TABLET modulates the immune system’s activity, helping to maintain
a balanced response that supports the survival of transplanted organs while
minimizing unwanted immune reactions.
!### Diarrhea
!### Nausea And Vomiting
!### Stomach Pain
!### Pregnancy
ContraindicatedIPCA MMF 500 TABLET is not recommended during pregnancy due to the high risk of
miscarriage and birth defects. Women planning pregnancy or who are pregnant
should inform their doctor before taking this medicine. Effective contrace
is essential for women of childbearing potential during management and for at
least 6 months after discontinuation. Consult your doctor if you are pregnant or
planning to conceive before taking this medicine.
!### Breastfeeding
ContraindicatedMycophenolate mofetil can passes into breast milk and may harm the nursing
infant. Breastfeeding is not advised during IPCA MMF 500 TABLET therapy. Discuss
alternatives with your healthcare provider if planning to breastfeed. Consult
with your doctor before taking it.
!### Driving and Using Machines
Use with CautionAvoid driving or using machinery if you experience side effects such as
drowsiness or dizziness or tremors or low blood pressure, or numbness.
!### Allergy
ContraindicatedDo not use IPCA MMF 500 TABLET if you have a known allergy to mycophenolate
mofetil or any other ingredient in the tablet.
!### Use In Pediatrics
Consult your doctorThis medicine is not recommended for use in children under the age of 2, because
there is limited information on its safety and effectiveness. Consult your
paediatrician before giving it.
!### Use In Geriatrics
Use with CautionElderly patients (65 years and above) should use IPCA MMF 500 TABLET cautiously,
especially if they are prone to viral infections, gastrointestinal bleeding, or
pulmonary oedema. Consult with your doctor before taking it.
Before Taking IPCA MMF 500 TABLET, Inform Your Doctor If You:
IPCA MMF 500 TABLET is not recommended for use if you:
| Lifestyle & Safety Measures | Details |
| Sun Protection for Photosensitivity | Limit direct sun exposure; wear protective clothing covering arms, legs, neck, and head; use sunscreen with high SPF to reduce skin damage risk. |
| Infection Risk Management | Avoid close contact with people showing signs of infection (e.g., chickenpox, shingles, flu), maintain good hygiene, frequent handwashing, and promptly report fever or signs of infection to your doctor. |
| Vaccination Precautions | Avoid live vaccines during IPCA MMF 500 TABLET therapy as they may cause infections due to weakened immunity. consult your doctor for updated vaccine schedules and alternatives. |
| Dietary Recommendations | Consume a balanced diet rich in fruits, vegetables, and protein to support overall health, avoid unpasteurized dairy, deli meats, and undercooked foods which increase infection risk. |
| Medication Adherence | Take IPCA MMF 500 TABLET on an empty stomach, 1 hour before or 2 hours after meals, unless advised otherwise, swallow tablets whole without crushing or chewing. |
| Regular Medical Monitoring | Attend routine blood tests to monitor immune function and detect potential side effects promptly, ensuring safe continued use. |
01)Proton Pump Inhibitors (e.g., Omeprazole, Pantoprazole, Lansoprazole)
Interaction:Taking IPCA MMF 500 TABLET with PPIs can reduce the effectiveness
of IPCA MMF 500 TABLET by lowering its levels in the body.
Effects: Decreased immunosuppressive activity may impact transplant organ
acceptance. Management: Inform your doctor if you are using PPIs; close
monitoring and possible dose adjustments may be required.
02)Certain Antibiotics (e.g., Sulfamethoxazole/Trimethoprim, Ciprofloxacin,
Amoxicillin) Interaction: These antibiotics can reduce the absor
effectiveness of IPCA MMF 500 TABLET. Effects: Lowered drug levels may
compromise medication performance. Management: Healthcare providers may
monitor for reduced efficacy and adjust doses accordingly.
03)Antacids Containing Aluminum or Magnesium (e.g., Maalox, Mylanta)
Interaction: May decrease IPCA MMF 500 TABLET absor
concurrently. Effects: Reduced drug levels can impact therapeutic
outcomes. Management: Separate administration times between IPCA MMF 500
TABLET and antacids; consult your doctor for guidance.
04)Other Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Sirolimus)
Interaction: Concurrent use with IPCA MMF 500 TABLET increases the risk of
additive immunosuppression and side effects. Effects: Elevated risk of
infections and toxicity. Management: Regular monitoring and dose
modifications as advised by healthcare practitioners.
05)Bile Acid Sequestrants (e.g., Cholestyramine, Colesevelam)
Interaction: Can reduce IPCA MMF 500 TABLET absor
Effects: Potential decrease in immunosuppressive action.
Management: Avoid simultaneous use or monitor drug effectiveness closely.
01)High-Fat Foods Interaction: Consuming high-fat meals around the time
of IPCA MMF 500 TABLET dosing can reduce the absor
Effects: Lowered medication levels may decrease its effectiveness.
Management: It is recommended to avoid fatty foods close to dose times and
take IPCA MMF 500 TABLET on an empty stomach for better absor
02)Deli Meats and Foods That May Contain Listeria Interaction: Foods like
deli meats, soft cheeses, and unpasteurized milk may carry Listeria bacteria,
posing a risk due to weakened immune response from IPCA MMF 500 TABLET.
Effects: Increased risk of infections and foodborne illness.
Management: Avoid these foods while on IPCA MMF 500 TABLET therapy to reduce
infection risks.
03)Raw or Undercooked Meats Interaction: Consum
raw meats can increase the likelihood of bacterial or viral infections.
Effects: Heightened risk of food poisoning, which can be severe in
immunocompromised patients. Management: Always consume thoroughly cooked
meats and practice food hygiene.
04)Alcohol Interaction:Alcohol may further suppress immune function and
interact negatively with IPCA MMF 500 TABLET. Effects: Increased
susce
Management: Limit or avoid alcohol during IPCA MMF 500 TABLET management,
consult your doctor for personalized advice.
05)Antacids Containing Aluminum or Magnesium Interaction: Certain
antacids can decrease IPCA MMF 500 TABLET absor
Effects: Reduced drug levels may impact therapeutic outcomes.
Management: Take antacids at least 2 hours after IPCA MMF 500 TABLET or
avoid concurrent usage.
| Drug | : | Mycophenolate mofetil |
| Pharmacological Category | : | Immunosuppressants |
| Therapeutic Indication | : | Immune Suppression |
| Dosage Forms | : | Tablet, Capsule, Suspension, Oral suspension |
A: IPCA MMF 500 TABLET supports management of organ transplant patients by
modulating immune response to help maintain the acceptance and long-term
function of transplanted kidneys, hearts, or livers.
A: IPCA MMF 500 TABLET contains mycophenolate mofetil, which reduces immune cell
activity involved in organ rejection by inhibiting a key enzyme required for
immune cell growth and replication.
A: It is advisable to take IPCA MMF 500 TABLET on an empty stomach, at least one
hour before or two hours after meals, to ensure o
effectiveness.
A: Patients may experience nausea, diarrhoea, headache, stomach pain, high blood
pressure, and increased risk of infections due to its immune-modulating effects.
A: IPCA MMF 500 TABLET is not recommended during pregnancy as it may cause birth
defects or pregnancy loss. Women of childbearing age should use effective
contrace
A: Avoid live vaccines, limit exposure to sunlight to reduce photosensitivity
risk, practice good hygiene to minimize infection risk, and attend regular blood
tests to monitor health status.
A: Visit the official medicalslot website, search for IPCA MMF 500 TABLET, upload a
valid doctor’s prescri
provide an accurate delivery address. medicalslot will verify your prescri
before processing the order to ensure you receive genuine medication safely at
your doorstep.